Development of a fiber modified adenovirus for safe gene therapy

被引：0
|
作者：
Yoon, AR [1 ]
Kim, E [1 ]
Kim, J [1 ]
Kim, JH [1 ]
Yun, CO [1 ]
机构：
[1] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
131
引用
收藏
页码：S51 / S52
页数：2
相关论文
共 50 条
  • [21] Adenovirus vectors for gene therapy
    Wilson, James M.
    Engelhardt, John
    Biotechnology Advances, 1997, 15 (3-4):
  • [22] Is gene therapy safe?
    Chronicle of Higher Education, 1999, 46 (17):
  • [23] Development of adenovirus and lentivirus vectors for anti-angiogenic gene therapy
    Shichinohe, T
    Nishida, M
    Jih, L
    Bochner, BH
    Kasahara, N
    CANCER GENE THERAPY, 1999, 6 (06) : S2 - S3
  • [24] Gene therapy - Is it safe?
    Tsang, L
    TOXICOLOGY, 2004, 194 (03) : 215 - 215
  • [25] Development of Helper-Dependent Adenovirus for Gene Therapy in the Inner Ear
    Phillips, Stacia
    Gu, Lintao
    Xu, Linjing
    Hansen, Marlan
    Young, Samuel
    MOLECULAR THERAPY, 2019, 27 (04) : 103 - 104
  • [26] Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo
    Wang, De-Gui
    Zhao, Mei-Jun
    Liu, Yong-Qiang
    Liu, Xiang-Wen
    Niu, Hai-Tao
    Song, Yan-Feng
    Tian, Ying-Xia
    ONCOTARGET, 2016, 7 (44) : 71710 - 71717
  • [27] EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus
    Kawashima, Rei
    Abei, Masato
    Fukuda, Kuniaki
    Nakamura, Kiminori
    Murata, Takehide
    Wakayama, Mariko
    Seo, Emiko
    Hasegawa, Naoyuki
    Mizuguchi, Hiroyuki
    Obata, Yuichi
    Hyodo, Ichinosuke
    Hamada, Hirofumi
    Yokoyama, Kazunari K.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (05) : 1244 - 1253
  • [28] Carcinoembryonic antigen - Targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors
    Tanaka, Toshihiro
    Huang, Jianhua
    Kuroki, Motomu
    Kuroki, Masahide
    Watanabe, Naoki
    Tomihara, Kei
    Kato, Kazunori
    Hamada, Hirofumi
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3803 - 3813
  • [29] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    Zhang, W.
    Ehrke-Schulz, E.
    Ehrhardt, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A127 - A128
  • [30] Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5
    Sallard, Erwan
    Schulte, Lukas
    van den Boom, Alexander
    Klimovitskii, Alexander
    Knierer, Julius
    Hagedorn, Claudia
    Knocks, Maximilian
    Zhang, Wenli
    Kreppel, Florian
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
12345